Objectives
The diagnosis of shaken baby syndrome (SBS) is difficult; the French High Authority for Health called “Haute Autorité de Santé” (HAS) introduced clinical and radiological criteria in 2017 to classify the diagnosis as “certain" or “probable." The aim of this study is to compare the clinical evolution of children with “certain" and “probable” diagnosis criteria of SBS.
Methods
Records of patients with a diagnosis of SBS according to HAS criteria, aged 1 to 16 months, admitted to a University Hospital between January 1st, 2008, and March 31st, 2018, were retrospectively analysed. Medical follow-up data were collected until December 31st, 2019. The primary endpoint was the Glasgow Outcome Scale (GOS) score at the end of hospitalization: the evolution was “favourable" if the GOS was equal to 5, and “unfavourable" if the GOS was lower than 5.
Results
107 children were included. The mortality rate was 10 %. There was no significant difference in the GOS score at the end of hospitalization between children with “certain" diagnosis and those with “probable" diagnosis (p = 0.75). There was no significant difference at last follow-up between these two groups. Among the children with an “unfavourable" outcome, 68 % had psychomotor developmental delay, 57 % had motor sequelae, 38 % had visual impairments and 36 % had epilepsy. Among those with a “favourable" outcome, 31 % had language disorders and 13 % had learning disorders. The GOS score at the end of follow-up was identical to the GOS at the end of hospitalization for 76 % of patients. It had improved for 14 % of the patients and had deteriorated for 10 % of the patients.
Conclusions
The “certain" or “probable" diagnosis of SBS according to HAS criteria does not modify the risk of sequelae during follow-up. Mortality and morbidity remain significant. Multidisciplinary management and specialized medical long-term follow-up are essential in both conditions.
扫码关注我们
求助内容:
应助结果提醒方式:
